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Abstract
Magnetic resonance imaging (MRI) techniques, such as magnetic resonance microscopy (MRM),
diffusion tensor imaging (DTI), and magnetic resonance spectroscopy (MRS), have recently been
applied to the study of both normal and abnormal structure and neurochemistry in small animals.
Herein, findings from studies in which these methods have been used for the examination of
animal models of Fetal Alcohol Spectrum Disorder (FASD) are discussed. Emphasis is placed on
results of imaging studies in fetal and postnatal mice that have highlighted the developmental
stage dependency of prenatal ethanol exposure-induced CNS defects. Consideration is also given
to the promise of methodological advances to allow in vivo studies of aberrant brain and behavior
relationships in model animals and to the translational nature of this work.
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Introduction
Studies employing animal models of prenatal alcohol (ethanol) exposure have been key to
defining how factors such as dosage, timing and pattern of consumption influence the range
of ethanol-induced functionalal and central nervous system (CNS) outcomes and to
elucidating ethanol's teratogenic mechanisms (reviewed by Goodlett et al., 2005; reviewed
by Cudd et al., 2005). Additionally, the establishment of fetal alcohol spectrum disorder
(FASD) animal models has provided the foundation needed for testing the effectiveness of
agents that may reduce ethanol-mediated birth defects (e.g. Ryan et al., 2008; Thomas et al.,
2000; 2004; 2007; 2009; 2010; Parnell et al., 2007; Serrano et al., 2010; reviewed by
Hannigan et al., 2007; Sari & Gozez, 2006; Klintsova et al., 2000).
FASD researchers have used many different model species, including zebrafish (e.g. Bilotta
et al., 2004), chicks (e.g. Marshall et al., 2009), guinea pigs (e.g. Green et al, 2005), sheep
(e.g. Ramadoss et al., 2007; Littner et al., 2008), non-human primates (e.g. Schneider et al.,
2001; 2002; Papia et al., 2010), and rodents (eg. Chernoff, 1977; Light et al., 1998; Sherwin
et al., 1979; West 1993). Of these, rodents have been most commonly employed (reviewed
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by Cudd et al., 2005). This is in part, because of their short gestational period, relatively low
cost, and well-characterized behavior and physiology. Mice have been particularly useful for
defining the stage-dependent teratogenic effects of ethanol (e.g. Webster et al., 1983,
reviewed by Sulik, 2005). As further described below, this is exemplified by the studies of
Sulik and her colleagues that have focused on discrete stages of embryonic development
(e.g. Godin et al., 2010; O'Leary-Moore et al., 2010; Parnell et al., 2009; Sulik et al., 1981;
Sulik & Johnson, 1982).
As early as 1981, Sulik et al. demonstrated that ethanol treatment limited to just the 7th day
of pregnancy in mice results in facial dysmorphology in the offspring that is consistent with
that in fetal alcohol syndrome (FAS) (see figure 1; Sulik et al., 1981). As shown in figure 1,
this includes microcephaly, an elongated upper lip, a deficient philtrum, a small nose and
short palpebral fissures. Gestational day (GD) 7 mouse embryos are at a stage in
development that is equivalent to that occurring early in the third week of human pregnancy;
a time when many women might not recognize that they are pregnant. It is at this early stage
of embryogenesis that gastrulation begins and the formation of the neural plate is initiated.
That exposure to ethanol during early gastrulation induces a spectrum of dysmorphology
most notably affecting the median aspects of the developing face and forebrain, including
holoprosencephaly (HPE) at the severe end of the spectrum, is now well-established
(reviewed by Lipinski et al., 2010; Higashiyama et al., 2007; Schambra et al., 1990;
Stockard, 1910; Sulik & Johnson, 1982; Sulik et al., 1984; Webster et al., 1983).
HPE is now recognized to be the most prevalent human birth defect occurring in as many as
1/250 conceptuses (Matsunaga & Shiota 1977). With most HPE-affected conceptuses being
lost prior to birth, this condition is reported in approximately 1/10,000 live births (Croen et
al., 1996; Leoncini et al., 2008; Shiota et al., 2007). HPE is known to result from a variety of
genetic abnormalities, as well as several different environmental factors. Among the latter is
ethanol, as evidenced in mice as described above, humans (Majewski, 1981; Peiffer et al.,
1979), and non-human primates (Astley et al., 1999; Siebert et al., 1991). Anomalies
consistent with those in the HPE spectrum are shown in figure 2. Illustrated are ethanol-
exposed mouse embryos with varying degrees of median tissue loss involving both the face
and brain (Sulik et al., 1984). This tissue deficiency is reflected in the abnormally close
proximity of the nostrils and loss of portions of the medial nasal prominences, accompanied
by closely approximated ganglionic eminences and a reduction in the size of the septal
region of the forebrain (figure 2). Other notable forebrain abnormalities following GD7
ethanol exposure in this model include hypoplasia or agenesis of the corpus callosum, as
well as deficiencies in the basal ganglia, hippocampus and anterior cingulate cortex (Sulik &
Johnston, 1982; Schambra et al., 1990; Sulik et al., 1984).
Recently, a number of studies utilizing state-of the art neuroimaging techniques to further
characterize brain anomalies associated with prenatal alcohol exposure in rodents have been
conducted. As reviewed herein, magnetic resonance imaging (MRI) and diffusion tensor
imaging (DTI) have been used to show stage-dependent alterations in brain structure. In
addition, magnetic resonance spectroscopy (MRS) studies have shown alterations in
neurochemistry following perinatal ethanol exposure. The results of this work have both
confirmed and extended previous observations. Clearly these animal-based studies have
significant translational potential, particularly regarding guidance of ongoing neuroimaging
investigations of individuals with FASD.
Magnetic Resonance Microscopy
Background—MRI is an imaging technique that provides a window into the anatomy of a
developing animal (reviewed by Driehuys et al., 2008). Aided by the development of high
field strength magnets (7 Tesla and above), custom coils, and the use of agents to enhance
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tissue contrast, the assessment of specimens using MRI at very high resolution (approaching
10 microns) is now possible. This high resolution imaging is referred to as magnetic
resonance microscopy (MRM) (Driehuys et al., 2008; Petiet et al., 2007; Turnbull and Mori,
2007). MRM is distinguished from more routine MRI by the spatial resolution of the scans
(~1mm3 for MRI vs. < 100 microns for MRM), by the diameter of the bore of the magnet
(~5 cm) limiting the size of the specimens that can be imaged, and by the amount of
scanning time needed. MRI can typically be completed within minutes when used for
routine clinical assessments. Until recently, MRM has required several hours of scanning
time for a single specimen, a factor that has limited its application to fixed tissue and to
studies employing relatively small numbers of samples. Technological advances now
provide for 21-43 micron isotropic resolution with scanning time in the order of 30-120
minutes per specimen. This speaks to MRM's potential as a high-throughput analysis
technique (eg. Johnson et al, 2007).
Recently, MRM has been successfully used to study the development of both prenatal and
postnatal animals and 3-dimensional atlases of mouse brain development are now published
(e.g. Chuang et al., 2011; Dhenain et al., 2001; Ma, Hof, et al., 2005, 2008; Petiet et al.,
2008). As shown in figure 3, MRM allows the imaging of embryos as young as 10.5 days
postfertilization (Petiet et al., 2008) and offers distinct advantages over traditional
histological techniques, including the ability to view the images in all three planes
simultaneously to assess morphology. From individual MRM scans, specific anatomical
regions can be segmented, i.e. parcellated either automatically or manually, using imaging
analysis software such as ITK-SNAP (Yushkevich et al.,2006) This allows accurate 3D
reconstruction (figure 4). While there has been an emphasis on MRM-based assessment of
the developing CNS, similar analyses of other organs such as the heart and kidneys (e.g.,
Petiet et al., 2008; Badea et al., 2006) and of specific regions such as the face are also
possible.
In order to characterize the stage-dependent effects of prenatal ethanol exposure on the fetal
brain more fully, Sulik and colleagues have recently initiated MRM-based analyses of fetal
and postnatal mice (Godin et al., 2010; O'Leary-Moore et al., 2010; Parnell et al., 2009). In
their studies, timed pregnant dams were treated with high doses of ethanol on single early
gestational days. Typically, treatment has entailed twice daily intraperitoneal injections of
2.8-2.9 g/kg ethanol administered 4 hours apart on either GD 7, 8, 9, 10 or 11. This
treatment results in blood ethanol concentrations approaching 350-420 mg/dl and models
acute high ethanol intake as occurs in an individual who is alcohol dependent. Because
ethanol-induced deficits at the severe end of the spectrum are often not compatible with
postnatal viability, many of the initial studies have focused on late fetal stages, i.e. GD17.
To date, GD17 brain dysmorphology resulting from acute high dose ethanol exposure on
GD 7, 8, and 10 has been characterized (Godin et al., 2010; O'Leary-Moore et al., 2010;
Parnell et al., 2009). Additionally, to ascertain the normal developmental trajectory at the
time of interest, the brains of GD 16, 16.5 and 17 fetuses have been assessed. As shown in
figure 5, and as determined from volumetric analyses, during this period in mice an increase
in overall brain size (38% increase in volume) is accompanied by a relative decrease in the
size of the ventricles. Because prenatal exposure to ethanol is known to result in generalized
growth retardation, recognition of these normal time-dependent changes is particularly
important as it provides for identification of appropriate control groups.
Qualitative analyses of acute early ethanol exposure-induced brain and facial
defects in mice—Consistent with earlier studies described above (Sulik & Johnston,
1982; Sulik et al., 1984), MRM scans and subsequent 3D reconstructions of the brains as
well as of the faces of fetal mice have illustrated that acute GD7 ethanol exposure results in
a spectrum of facial and CNS effects that commonly includes HPE in the most severely
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affected fetuses (Godin et al., 2010). As shown in figure 6, affected fetuses having varying
degrees of median facial anomalies typically also present with forebrain deficiencies. The
facial abnormalities range from a slight narrowing of the nose (i.e. nostrils that are
somewhat closely approximated) and an upper lip that has a slightly diminished central
notch, to extreme narrowing of the snout and absence of the nostrils. The lower jaw is also
commonly involved and often appears narrow and short as compared to controls. In general,
the brains of animals with the more severe facial dysmorphia are more affected. In mildly
affected ethanol-exposed fetuses, the overall form of the brain appears fairly normal, though
the olfactory bulbs appear smaller and the space between the cerebral hemispheres is
somewhat narrow as compared to controls. As the severity of teratogenesis increases, the
olfactory bulbs may be absent, accompanied by cerebral hemispheres that are united across
the midline. In severely affected specimens the cerebral tissue can be quite minimal, while
the more caudal aspects of the brain appear relatively normal. In addition to these defects,
GD7 ethanol exposure-induced abnormalities identified with MRM include cleft palate,
aglossia, pituitary dysgenesis, aqueductal stenosis, and eye anomalies ranging from slight
microphthalmia to bilateral anophthalmia (Godin et al., 2010).
The ability to accurately reconstruct the MRM scans of the face and brain of individual
specimens allows correlative analyses with outcomes that should be indicative of the value
of facial dysmorphology assessments in affected children to predict the involvement of the
brain. That useful translational data will be forthcoming from these studies is supported by
the fact that sophisticated 3D shape analysis and dense surface modeling has been applied to
identification of human craniofacial changes in autism (Hammond et al., 2008) and in a
variety of genetic conditions (e.g. Hammond et al., 2005). These shape analysis techniques
have also recently been applied in an FASD study and have identified facial asymmetry in
some affected individuals (Klingenberg et al., 2010). Other recently reported human
morphometric and 3D analysis data regarding abnormalities in the shape of the face have
provided for the classification of children with FAS (e.g. Mutsvangwa & Douglas, 2007;
Mutsvangwa et al., 2010). Facial morphometric techniques have also been applied to a
mouse model to define strain-dependent ethanol-induced alterations with results indicating
deficiencies in facial depth measures following GD7 exposure (Anthony et al., 2010), a
finding that is consistent with the “flattened midface” associated with FAS (Moore et al.,
2007). Additionally, recent work by Sowell and colleagues (Roussotte et al, in press)
describes face/forebrain correlations that are consistent with patterns of face and forebrain
deficits that result from GD7 ethanol exposure in the mouse (Godin et al, 2010).
Recognizing that acute ethanol exposure at times other than GD7 does not result in the HPE-
related facial phenotype and that later exposure times yield different patterns of facial and
brain anomalies in the mouse (Sulik et al., 1986; Kotch & Sulik, 1992), it will be of interest
to include discrete exposure times as a critical variable in face/brain correlation outcomes.
The results of such studies hold particular promise in informing clinical FASD
investigations and diagnoses.
Importantly, in addition to being useful in demonstrating severe dysmorphology resulting
from ethanol exposure-induced teratogenesis, MRM has facilitated the discovery of subtle
brain defects in mice. These could easily have been missed with conventional histological
techniques. As shown in figure 7, 3D reconstructions of the brains of fetuses that had been
exposed to ethanol on GD7 revealed cerebro-cortical surface irregularities that have been
confirmed as leptomeningial heterotopias (Godin et al., 2010). Recognition that such early
ethanol exposure can result in heterotopias is of considerable clinical significance. Errors in
cell migration, the basis for heterotopia formation, have been implicated in seizures. Recent
clinical reports have revealed heightened rates of both seizures and epilepsy among
individuals with FASD (Bell et al., 2010; Sun et al., 2009), with first trimester ethanol
exposure being most commonly involved (Bell et al., 2010). A recent case report of an
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individual with FAS described seizure activity and the detection of polymicrogyria with
MRI (Reinhardt et al., 2010). Interestingly, ethanol exposure on GD10 in the mouse also
resulted in heterotopic tissue formation. However, rather than being localized to the cortex,
the heterotopia extended into the third ventricular space (O'Leary-Moore et al., 2010).
While MRM-based studies of acute GD8 ethanol exposure-induced defects have identified
neither HPE nor heterotopia formation, other morphological changes involving the brain,
eyes and facial structures have been found (Parnell et al., 2009; O'Leary-Moore et al., 2010).
Included are optic nerve coloboma, choanal atresia, narrowing of the cerebral aqueduct, and
third ventricle enlargement (Parnell et al., 2009). Third ventricular dilation has also been
noted in MRM scans of fetuses that had been exposed to ethanol on GD10 (O'Leary-Moore
et al., 2010). 3D reconstructions of the ventricular system of these specimens are illustrated
in figure 8. These results suggest that the tissue surrounding the third ventricle, including the
thalamus and hypothalamus are deficient (O'Leary-Moore et al., 2010) and studies to
examine this possibility are currently underway.
Quantitative analyses of acute early ethanol exposure-induced brain defects
in mice—One of the major advantages of MRM is that it allows regional brain
segmentation and subsequent characterization of region-specific alterations including
volumetric changes. Indeed, volumetric changes have been reported in human FASD
imaging-based brain studies (Norman et al., 2009; Spadoni et al., 2007; Riley et al., 2004).
Among these findings are volume deficits in various cortical (e.g. Archibald et al., 2001;
Sowell, Thompson, et al., 2001; 2002; Bjorkquist et al., 2010) and subcortical structures
(Mattson et al., 1992; 1994; 1996; Cortese et al., 2006), and the cerebellum (Sowell et al.,
1996; O'Hare et al., 2005), along with alterations in cortical thickness (e.g. Sowell, Mattson,
et al., 2008) and changes in the shape and size of the corpus callosum (e.g. Bookstein,
Streissguth et al., 2002; Sowell et al., 2001). In the acute early gestational exposure mouse
model, expected volume reduction in telencephalic structures accompanied by increased
lateral ventricular volume was apparent in holoprosencephalic fetuses that had been exposed
to ethanol on GD7. As previously noted, in these fetuses there is relative sparing of
mesencephalic and rhombencephalic brain regions (Godin et al., 2010). Among less severely
affected fetuses (those without apparent facial dysmorphology) from this exposure time,
larger third ventricle volumes were found (Godin et al., 2010). Acute GD8 ethanol exposure
caused disproportionate reductions in the volume of the olfactory bulbs, hippocampus and
cerebellum while the septal region and pituitary volumes were disproportionally increased
(Parnell et al., 2009). A global effect on total brain volume was found following GD10
ethanol exposure. In order to distinguish a global developmental delay from true ethanol-
induced dysmorphology, ethanol-exposed subjects were compared to developmental stage-
matched controls that were chronologically half a day younger. As compared to these
morphologically matched controls, third ventricular volume enlargement was particularly
evident; a finding consistent with visual inspection of the 3D third ventricle renderings
(figure 8; O'Leary-Moore et al., 2010).
Linear measurements are also readily ascertained from MRM scans of fetal mouse brains
and provide data that can be easily compared to that from human fetal ultrasounds (figure 9).
Comparable findings from human fetuses (Kfir et al., 2009) and from fetal mice following
GD7 ethanol exposure (Godin et al., 2010) include reductions in frontothalamic distances
and biparietal diameter. Linear measurements from fetuses that had been exposed to ethanol
on GD8 revealed reduction in the transverse cerebellar diameter and both GD8 and GD10
ethanol exposure preferentially increased third ventricular width (Parnell et al., 2009;
O'Leary-Moore et al., 2010). The translational value of this type of quantitative analysis is
evident with respect to potential FASD prenatal diagnosis.
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Persistence of ethanol-induced brain dysmorphology—Both structural and
functional studies assessing the impact of prenatal ethanol exposure on the adolescent and
adult mouse have commenced. Consistent with data from fetal mice, a spectrum of ethanol-
induced effects has been found in adolescent animals. As in prenatal specimens following
GD7 ethanol exposure, HPE occurs. However, the viability of these severely affected
animals is diminished so only a few adolescents or adults have been studied (Sulik, 2005).
Additionally, hydrocephalus, a condition in which there is excessive accumulation of CSF in
the ventricles causing the cortical tissue to thin and the skull to enlarge, has been recognized
around the time of weaning among several GD7 ethanol-exposed animals (unpublished
observations). MRM-based 3D reconstructions of the ventricles have shown marked
narrowing of the isthmus of the cerebral aqueduct in some ethanol-exposed fetuses (Godin et
al., 2010). This condition; i.e. aqueductal stenosis, is expected to play a significant role in
the genesis of the hydrocephalic condition. Among the more subtle brain defects observed
via MRM in postnatal animals are dilated ventricles in the absence of macrocephaly,
abnormal striatum and hippocampi, and partial agenesis of the corpus callosum, all of which
follow GD7 ethanol insult (figure 10). These findings are very similar to those in individuals
with FASD (reviewed by Norman et al., 2009).
Diffusion tensor imaging
Background—Diffusion tensor imaging (DTI), as reviewed by others and Wozniak in this
volume, is based on the diffusion properties of water and allows the assessment of the
integrity of fiber tracts, even in the absence of gross dysmorphology (Chanraud et al., 2010;
Wozniak & Muetzel, 2011). The application of DTI to the study of FASD has provided a
plethora of information regarding various white matter regions of the brain that are
particularly susceptible to ethanol teratogenesis. To date, a major human DTI focus has
involved measures of Fractional Anisotropy (FA) and Mean Diffusivity (MD) to
characterize ethanol-induced abnormalities of the corpus callosum (Ma, Coles et al., 2005;
Sowell, Johnson et al., 2008; Fryer et al., 2009; Li et al., 2009, Wozniak et al., 2006; 2009;
Lebel et al., 2008; 2010).
DTI is particularly effective for studies of brain development in both humans (Huppi &
Dubois, 2006; Huang et al., 2006) and animals (Chahbourne et al., 2007; Chuang et al.,
2011; Mori & Zhang, 2006; Zhang et al. 2006;). As opposed to traditional imaging
techniques, high-resolution DTI scans in the developing mouse brain provide superb
contrast, allowing visualization of fiber tracts even in regions of the brain where myelination
has not yet begun (e.g. Zhang et al., 2003; 2006). From DTI data, specialized data analysis
software such as DTIStudio (Jiang et al, 2006) and Slicer3 (Pieper et al, 2004; 2006) can be
used to create color-coded anisotropy maps in which differing fiber orientations are
represented by color-codes and in which the intensity of the signal represents the degree of
diffusion anisotropy (i.e. FA; reviewed by Wozniak in this edition). As shown in figure 11,
Zhang and colleagues (2003) applied DTI to the study of mouse prenatal brain development
and the resulting images provide remarkable detail regarding the location and preferential
direction of fiber tracts and cortical layers. In the DTI images from this study, various
neuroepithelial layers including the cortical plate and intermediate zone, as well as the major
fiber tracts are visible as early as GD12 in mice (see figure 11).
DTI-based studies of ethanol teratogenesis in a mouse model have recently been initiated.
As shown in figure 12, non-diffusion weighted and color-coded anisotropy maps allow
visualization of both normal and aberrant morphology of major fiber tracts in the fetal
mouse brain. Consistent with MRM-based analyses, prenatal ethanol exposure on GD7
induces anomalies apparent with DTI that are within the HPE spectrum. Exemplary are
differences in non-diffusion weighted images of a control mouse fetus where the septal
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region, olfactory bulbs, and distinct striatal regions and lateral ventricles can be appreciated,
and of an ethanol-exposed animal in which the cerebral cortices are joined at the midline,
the septal region and olfactory bulbs are absent, the striata are too closely approximated, and
a single telencephalic ventricle is present. Color-coded anisotropy maps, which indicate the
preferential orientation of diffusion, clearly show fiber tract anomalies in ethanol-affected
fetal mice. Notable defects in the fetus shown in figure 12 involve the internal and external
capsule, as well as the fimbria/fornix. Additionally, abnormal fibers projecting across the
midline (as indicated by their red color-encoding) rostral to the thalamic region (figure 12 f),
as well as abnormal fibers projecting in the superior/inferior direction (as indicated by their
blue color-encoding) in the midline of the brain are present (figure 12 h). As opposed to
traditional histological techniques where only the presence of the abnormal fibers can be
confirmed, DTI provides information regarding the preferential orientation of these aberrant
fibers.
DTI has proven particularly informative for analysis of GD7-induced ethanol brain defects
by illustrating that even in the absence of readily discernable facial abnormalities, fiber tract
alterations occur. An example is shown in figure 13 in which a control and an ethanol-
exposed subjects’ faces, 3D brain reconstructions and midsagittal sections of the color-
coded anisotropy map are readily compared. Despite having a normal appearing face and a
brain with two distinctly separate cerebral hemispheres, the corpus callosum of the affected
fetus is diminished. Recent studies have been extended to characterize anomalies in the
postnatal animal, with an initial emphasis on characterizing anomalies involving the midline.
Preliminary data indicate that as compared to a control, in which the corpus callosum can be
identified as a broad midline band (figures 14, 15 a), variable degrees of narrowing,
particularly in the mid-region are apparent (figure 15 c & e). These findings are consistent
with clinical reports of corpus callosum anomalies in humans (Bookstein, Sampson et al.,
2002; Sowell, Mattson et al., 2001; Riley et al., 1995; Swayze et al., 1997).
Expanding DTI's potential to inform FASD studies is the ability to develop 3D fiber tract
reconstructions as shown in figure 16 (Mori & van Zijl, 2002; Jiang & Johnson, 2010) and
as described by Wozniak in this publication. Not only does this technique provide for
morphological assessments, it offers the potential for quantitative analyses of various
properties of diffusion along the tracts of the reconstructed fibers. Ongoing studies in
prenatal and postnatal mice are also employing this technology with preliminary data being
most promising.
Magnetic Resonance Spectroscopy
MRS is a non-invasive imaging technique that provides biochemical information about
localized brain regions (reviewed by Moore & Galloway, 2002; van der Graaf, 2010). It has
been widely applied to study brain maturation and disorders involving the CNS (e.g. Kreis et
al., 2002; Vigneron 2006; Girard et al., 2006; Choi et al., 2007). MRS probes can be tuned
to study a number of different molecular nuclei that are present in our bodies but among the
most commonly studied with MRS is the hydrogen nucleus (proton - 1H). 1H MRS allows
the quantification of various neurochemicals in the brain, including N-acetyl aspartate
(NAA), a marker of neuronal integrity; choline, which is essential for the synthesis of
acetylcholine and the cell membrane constituent phosphatidylcholine; and creatine, which is
important for maintaining energy-dependent systems within the cell (reviewed by van der
Graaf, 2010). With some higher field magnets and specialized pulse sequences, other
neurochemicals such as myoinositol, glutamate and GABA can be measured. MRS data are
expressed in a spectrum (e.g. see figure 17); the horizontal axis is called the chemical shift
and each neurochemical has its own unique location(s). The vertical axis represents the
strength of the signal and the area under it is proportional to the number of protons in the
sample. MRS has been of interest for FASD research because of its potential to uncover a
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biomarker of prenatal alcohol exposure and, while results have generally been
inconsistent, 1H MRS has been applied to the study of neurochemistry following prenatal
ethanol exposure, (Astley et al., 1995; 2009; Cortese et al., 2006; Fagerlund et al., 2006).
Utilizing an animal model of neonatal ethanol exposure, where ethanol was administered to
the offspring early during postnatal life to imitate 3rd trimester exposure in the human,
regional brain neurochemistry in developing rats was examined (O'Leary-Moore et al.
2008). Using a specialized MRS technique called high-resolution magic angle spinning
(HR-MAS 1H MRS), neurochemical data from intact tissue biopsies was ascertained and
quantified. Figure 17 illustrates the appearance of an HR-MAS 1H MRS spectrum as well as
the chemicals that are readily quantified using this technique. Following neonatal ethanol
exposure, region-specific alterations in a number of neurochemicals were found, with
alterations in the cerebellum being most pronounced. This is consistent with the results of
previous studies examining alterations in the cerebellum following binge ethanol exposure
in the neonatal rat (e.g. Green et al, 2004). For both male and female ethanol-exposed rats,
cerebellar levels of NAA and taurine (an antioxidant and inhibitory neuromodulator) were
reduced and glutamate levels were lower in females as compared to controls. In addition,
cerebellar myo-inositol (a glial marker) levels were elevated. Reductions in striatal NAA
and taurine were also apparent following ethanol exposure (O'Leary-Moore et al., 2008).
The potential for future studies to characterize neurochemical alterations induced by
different periods of exposure, as well as to test the ability of various treatments to reverse
these neurochemical effects, is promising.
Conclusions
A number of factors including genetics, maternal age, polydrug exposure, nutritional status,
and the dose, timing and pattern of ethanol intake during gestation all interact to produce a
range of effects on the developing offspring (e.g. Abel & Hannigan, 1995; Chiodo, et al.,
2010; Keen et al., 2010; Warren & Li, 2005). Studies in animal models can control for these
factors and have been instrumental in increasing our understanding of the mechanisms
underlying ethanol teratogenesis, critical exposure periods, dose-response relationships and
the pathology resulting from prenatal ethanol exposure. Regarding the latter, while imaging
techniques such as MRI, DTI and MRS have only recently been applied to examination of
pathology in FASD animal models, they have greatly facilitated new and important
discoveries.
Expected technological imaging advances will undoubtedly facilitate the extension of
existing basic FASD studies. Of particular interest will be the application of advanced
imaging methods to assessment of potential low dose teratogenic effects, gene-environment
interactions, and mitigation of the adverse consequences of ethanol insult. Additionally, in
vivo high resolution imaging may become practical; an advance that will afford the ability to
correlate prenatal ethanol-induced behavioral and morphological abnormalities in
longitudinal studies of single experimental animals.
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Acronyms
CNS central nervous system
DTI diffusion tensor imaging
FAS Fetal Alcohol Syndrome
FA fractional anisotropy
MD mean diffusivity
FASD Fetal Alcohol Spectrum Disorders
HPE holoprosencephaly
HR-MAS MRS high-resolution magic angle spinning magnetic resonance spectroscopy
MRI magnetic resonance imaging
MRM magnetic resonance microscopy
MRS magnetic resonance spectroscopy
NAA n-acetyl aspartate
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Shown in (a) is a child with the characteristic facial features of FAS. These features include
microcephaly, small palpebral fissures, small nose, an indistinct philtrum and a thin
vermillion border. In (b), a mouse fetus that had been exposed to ethanol on gestational day
7 shows similar features to the child with FAS. For comparison, a normal mouse fetus is
pictured in c. Modified with permission from KK Sulik et al. Fetal alcohol syndrome:
embryogenesis in a mouse model. Science 214:936–938, Copyright © 1981 American
Association for the Advancement of Science; and KK Sulik, Genesis of Alcohol-Induced
Craniofacial Dysmorphism Exp Biol Med, 230(6):366-375, Copyright © 2005 The Royal
Society of Medicine Press.
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The face and brain of a normal gestational day (GD) 11 mouse embryo (a, b), as compared
to the faces and the brains of two ethanol-exposed embryos (c d; e f ), illustrate the range of
defects induced by GD7 ethanol insult. In the ethanol-exposed embryos, loss of midline
tissue is notable. Abnormally close apposition of the nostrils (circles) and absence of
portions of the medial nasal prominences (m) can be seen in the faces of the ethanol-affected
embryos. Similar abnormal proximity of the ganglionic eminences (arrows) can be
appreciated (d, f), as can reduction and absence of the septal region (s; d, f). Modified with
permission from Sulik KK, Lauder JM, Dehart DB. Brain malformations in prenatal mice
following acute maternal ethanol administration. Int J Dev Neurosci 2:203–214, Copyright
© 1984 Elsevier and Sulik, Genesis of Alcohol-Induced Craniofacial Dysmorphism Exp
Biol Med, 230(6):366-375, Copyright © 2005 The Royal Society of Medicine Press.
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Detailed examination of prenatal development in the mouse beginning at GD10.5 through
GD19.5 is possible utilizing high-resolution MRM. Modified with permission from AE
Petiet, et al., High-resolution magnetic resonance histology of the embryonic and neonatal
mouse: a 4D atlas and morphologic database, Proc Natl Acad Sci U S A. 105(34):
12331-12336, 2008; Copyright © 2008, National Academy of Sciences, U.S.A.
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MRM scans of GD17 fetuses allow for assessment of the brain in three planes
simultaneously (a, sagittal; b, coronal; c, horizontal) and for the creation of three-
dimensional reconstructions (d). Color-coded regions illustrate brain areas that were
manually segmented for volumetric analyses. In d, the upper right portion of the brain image
was removed to allow for visualization of the interior structures. From SK O'Leary-Moore et
al., 2010, Magnetic resonance microscopy-based analyses of the brains of normal and
ethanol-exposed fetal mice, Birth Defects Research Part A: Clinical and Molecular
Teratology; Copyright © John Wiley & Sons, Inc.; modified from Parnell et al. 2009 &
Godin et al. 2010.
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Three dimensional brain and ventricular reconstructions from control GD16, GD16.5, and
GD17 mouse fetuses are illustrated. Dorsal (a, e, i) and lateral (b, f, j) aspects of the brain
are shown, as are dorsal ventricular (c, g, k) and lateral third/fourth & mesencephalic
ventricular (d, h, l) reconstructions. The increase in brain volume during development is
apparent and the changing morphology of the olfactory bulbs is particularly evident. In
contrast, the relative size of the ventricles to total brain volume actually decrease with age
(c, d, g, h, k, l). Alterations are particularly pronounced in the lateral magnetic resonance
microscopy reconstructions of the third, mesencephalic and fourth ventricle reconstructions
(d, h, l). Specifically, the dorsal part of the third ventricle (arrow in d) is wider and gets
progressively smaller with age. From O'Leary-Moore et al., Magnetic resonance
microscopy-based analyses of the brains of normal and ethanol-exposed fetal mice, Birth
Defects Research Part A: Clinical and Molecular Teratology; Copyright © 2010 John Wiley
& Sons, Inc
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Illustrated are a spectrum of facial and brain anomalies that result from GD7 ethanol
exposure. As compared to the control (a), those animals exposed to ethanol prenatally (b-e)
show varying degrees of facial dysmorphology characterized by an elongated upper lip with
a diminished philtral region, closely spaced nostrils, and a small mandible. Brain anomalies
also fall along a spectrum of effect and are shown from least to most severe in MRI-based
3D reconstructions. Note that in the animal with the most subtle facial dysmorphology (b),
the brain (g), appears to be relatively normal. In the animals where facial dysmorphology is
more pronounced, the brains are more affected (h, i), and have malformations consistent
with holoprosencephaly. The animal whose brain depicted in (j), is missing most of its
telencephalon and has a severe facial phenotype, with only one nostril and no lower jaw (e).
Pink: olfactory bulbs, Red: cerebral cortex, lime green: diencephalon, magenta: midbrain,
blue: cerebellum, light blue: mesencephalic/ 4th ventricle, green: hindbrain.
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A 3D brain reconstruction (a), coronal MRI scan (b) and a histological section (c) illustrate
the presence of cortical heterotopias resulting from GD7 ethanol exposure in a mouse fetus
and demonstrate the utility of MRM in identifying such malformations. Modified with
permission from EA Godin et al., Magnetic resonance microscopy defines ethanol-induced
brain abnormalities in prenatal mice: effects of acute insult on gestational day 7.
Alcoholism: Clinical and Experimental Research, 34(1), 98-111. Copyright © 2010 John
Wiley & Sons, Inc.
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3D reconstructions of the third and mesencephalic/4th ventricles of a control (a) and 6 GD10
ethanol-exposed mouse fetuses (b-g). Third ventricular dilation is evident in all subjects
particularly in regions surrounded by the thalamus (arrow) and hypothalamus (arrowhead).
Enlargement of the mesencephalic ventricle was also apparent (dashed arrow, G). From
O'Leary-Moore et al., in press, Magnetic resonance microscopy-based analyses of the brains
of normal and ethanol-exposed fetal mice, Birth Defects Research Part A: Clinical and
Molecular Teratology; Copyright 2010 © John Wiley & Sons, Inc
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Brain linear measurements are readily ascertained from ultrasound images of the human
fetus (a-c, represented in d-f) and from MRM images of the fetal mouse brain (g-i),
highlighting the potential for translational FASD studies. TCD – transverse cerebellar
diameter, OFD – orbitalfrontal distance, CCD – caval calvarial distance, FTD –
frontothalamic distance, OOD – outer ocular diameter, IOD – inner ocular diameter.
Reprinted with permission from Kfir et al., Can prenatal ultrasound detect the effects of in
utero alcohol exposure? A pilot study. Ultrasound Obstet Gynecol, 33(6) 683-9, Copyright
© 2009, ISUOG, Published by Wiley & Sons, Ltd.
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Horizontal, midsagittal and coronal sections from MRI scans of a control (a–c) and a GD7
ethanol-exposed (d-f) adolescent male mouse illustrate significant brain anomalies that
result from prenatal ethanol insult. As compared to the control (a), significantly enlarged
lateral ventricles (black dashed arrow in d) and an abnormally shaped fornix (dashed white
arrow) are apparent. The striatum and corpus callosum appear to be reduced in size after GD
7 ethanol exposure (d, stars and black arrow, respectively). Anomalies in the corpus
callosum are especially apparent, where the middle part (body), is absent (e). Sections in the
coronal plane also show dilation of the lateral ventricles (dashed arrow in f), as well as an
abnormal corpus callosum (black arrow in d) and dysmorphic hippocampi (white arrow in d)
in the ethanol-exposed subject as compared to the control subject (c). Modified from
O'Leary-Moore et al., in press, Magnetic Resonance-Based Studies of Fetal Alcohol
Spectrum Disorder in Animal Models. Alcohol Research & Health. National Institute of
Alcohol Abuse and Alcoholism (NIAAA).
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Diffusion tensor imaging illustrates normal brain development during the prenatal period. In
embryos as young as 12 days post-fertilization, cellular orientation in the neuroepithelium
(NE) can be appreciated (A, blue arrowhead), and 24 hours later, the cortical plate (CP, pink
arrowhead) and intermediate zone (IZ, yellow dot) can be distinguished. As development
progresses, the cortical plate extends from its original lateral location, rostrally and towards
the midline, where neurons are oriented perpendicular to the surface of the brain. The
intermediate zone is also developing at this time, with its cellular orientation parallel to the
surface of the brain as seen in A. The development of these layers can also be appreciated in
the schematic depicted in the box in B. Also shows in B are developmental changes in the
thickness of the cortical plate from embryonic day 8 through GD18. Commissural fibers, as
shown in C, are readily appreciated by GD17 and include the optic chiasm (white
arrowhead), hippocampal commissure (yellow arrowhead), anterior commissure (pink) and
corpus callosum (blue arrowhead). Reprinted with permission from J. Zhang et al., Three-
dimensional anatomical characterization of the developing mouse brain by diffusion tensor
microimaging, NeuroImage, 20(3), 1639-1648. Copyright © 2003, Elsevier.
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Non-diffusion weighted images and color-coded fractional anisotropy (FA) maps illustrate
normal brain and fiber tract morphology of a control mouse (a-d) and aberrant morphology
in a GD7 ethanol-exposed mouse (e-h). As compared to the non-diffusion weighted images
of a control mouse (a, c) where the septal region (black arrow), olfactory bulbs (white
arrow) and caudate nuclei (stars) appear normal, in the scans of the subject that had been
exposed to ethanol (e, g), the olfactory bulbs and septal region are absent and the striatum
are too closely approximated. Color-coded FA maps show fiber tract defects resulting from
GD7 ethanol exposure (f, h). As compared to the normal appearance of the internal and
external capsule in the control (b, yellow and green arrows, respectively), the subject
exposed to ethanol prenatally has a significantly thickened internal capsule (yellow arrow)
which appears to cross the midline (pink arrow in f). Similarly, the external capsule of the
ethanol-exposed fetus also appears to be united across the midline of the brain (green arrows
in f).
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DTI reveals subtle dysmorphology in a GD 17 fetus following GD7 ethanol exposure. Like
the control face (a) and brain (b), those of an ethanol-exposed subject (d, e) appear grossly
normal. In the control fetus, color-coded FA maps show a midsagittal section of the brain
where the corpus callosum (white arrow), hippocampal commissure (red arrow), fornix
columns (orange arrow) and anterior commissure (yellow arrow) are apparent. However, in
an ethanol-exposed fetus, the color-coded FA map shows that the corpus callosum of the
ethanol-exposed animal (f) appears to be almost completely absent while other fiber tracts
appear normal.
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Non-diffusion weighted (a), FA (b), and color-coded FA (c) images illustrate the normal
morphology of the adolescent mouse brain in a midsagittal section. In (b), regions with high
signal that appear white are white matter regions of the brain. The color-coded FA maps also
show regions of white matter and the colors of the different fibers represent the preferential
direction of diffusion of the various fibers. Fibers that are red such as the corpus callosum,
project in the right/left direction, green fibers project in the anterior/posterior direction and
blue fibers project in the inferior/superior direction. Shown in (d) is an enlarged region of
the color-coded FA maps emphasizing midline regions of interest. The corpus callosum
(CC), ventral and dorsal hippocampal commissures (HC,v and HC,d), anterior commissure
(AC), fornix column (F,c) and cingulum (Cing) are readily distinguishable.
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Color-coded FA maps from a control mouse (a) and two GD 7 ethanol exposed mice (c, e)
with varying degrees of brain dysmorphology. As compared to the control (a), the mouse in
(c), has mild thinning of the corpus callosum in the middle section (star in c) and the mouse
brain depicted in e has reduced size of the corpus callosum in the anterior and posterior
sections (arrows) and the middle part of the corpus callosum is absent. The hippocampal
commissure (yellow arrows) is also reduced in the more severely affected mouse (e).
Dysmorphology of the corpus callosum in this mouse model is remarkably similar to that
seen in individuals with FAS. As compared to a control individual (b), those with FAS (d, f)
also have considerable dysmorphology of the corpus callosum. Human images courtesy of
Dr. S. Mattson.
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Fiber tracking allows 3D reconstruction of major fiber tracts in the adult mouse brain. A
lateral (a) and ventral view (b) of fiber tracts from an individual brain are overlaid on
anatomical regions of a reference brain. Fiber tracts shown are: corpus callosum (red),
cingulum (cyan), anterior commissure (blue), fimbria (white), optic tract (green), and
habenular commissure (pink). Anatomical regions illustrated in transparent colors include
the olfactory bulbs (light blue), anterior commissure (purple), fimbria (green), hippocampus
(yellow), septal nuclei (brown), and cerebral cortex (dark blue). Reprinted with permission
from Y. Jiang et al., Microscopic diffusion tensor imaging of the mouse brain, NeuroImage,
50(2), 465-471, Copyright © 2010, Elsevier.
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Illustrated in (A) is a representative spectra from an adult male rat striatum. Neurochemicals
that can be resolved include (from left to right): mI — myo-inositol, Cre — creatine, GSH
—glutathione, Glu — glutamate, Gly — glycine, Tau — taurine, Bet — betaine, GPC —
glycerophosphorylcholine, PCh — phosphorylcholine, Cho — choline, PEA —
phosphorylethanolamine, GABA — gamma-aminobutyric acid, Asp — aspartate, NAA —
N-acetyl-aspartate, Gln — glutamine, Pyr — pyruvate, NAAG — N-acetylaspartyl
glutamate,Ala — alanine, Lac — lactate. In (B), region-dependent alterations are shown in
levels of NAA. Reprinted with permission from S. O'Leary-Moore et al., Neonatal alcohol-
induced regions-dependent changes in rat brain neurochemistry measured by high-resolution
magnetic resonance spectroscopy, Alcohol Clin Exp Res, 32(10), 1697-707, Copyright ©
2008, Elsevier.
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